Latanoprost Ciclum

Latanoprost, the active ingredient in Latanoprost Ciclum, is a prostaglandin analog presented as a 0.005% ophthalmic solution for ocular use. It is indicated for the management of open‑angle glaucoma and ocular hypertension in adult patients, helping to lower intra‑ocular pressure and preserve visual function. GNH USA supplies Latanoprost Ciclum as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Latanoprost Ciclum belongs to the prostaglandin analog class and is used to manage conditions that involve elevated intra‑ocular pressure. - Open‑angle glaucoma: reduces intra‑ocular pressure to slow disease progression. - Ocular hypertension: lowers eye pressure to prevent development of glaucoma. - Post‑surgical ocular pressure control: helps maintain target pressure after ocular surgery.

Latanoprost may cause a range of ocular and systemic reactions.

Common Side Effects: - Eye redness: mild conjunctival hyperemia. - Eyelash changes: increased length, thickness, or darkness. - Eye irritation: transient burning or stinging on instillation. - Blurred vision: temporary visual disturbance. - Iris pigmentation: gradual darkening of the iris. - Periorbital skin darkening: mild hyperpigmentation around the eye.

Serious or Rare Side Effects: - Severe allergic reaction: swelling, rash, or difficulty breathing. - Uveitis: inflammation of the uveal tract. - Corneal edema: swelling of the cornea affecting vision. - Paradoxical IOP increase: unexpected rise in intra‑ocular pressure. - Endophthalmitis: intra‑ocular infection requiring urgent care. - Persistent eye pain: may indicate underlying complication.

Before initiating therapy with Latanoprost Ciclum, consider the following precautions. - Baseline assessment: measure intra‑ocular pressure and document iris color. - Monitor changes: watch for iris darkening or eyelash growth that may be cosmetically concerning. - Ocular infection: avoid use in eyes with active infection or inflammation. - History of uveitis: use with caution; monitor for signs of inflammation. - Contact lens wear: advise patients to remove lenses before and after instillation. - Store at room temperature: keep in original container, protect from moisture and light.

Latanoprost may interact with other ocular or systemic agents.

Major Interactions (Avoid): - Concurrent prostaglandin analogs: additive IOP‑lowering effect may cause hypotony. - Systemic carbonic anhydrase inhibitors: excessive reduction of intra‑ocular pressure.

Moderate Interactions (Monitor Closely): - Topical ocular NSAIDs: may increase risk of ocular inflammation. - Beta‑blocker eye drops: monitor for excessive IOP reduction. - Systemic antihistamines: possible dry eye exacerbation.